| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chairman &CEO | President &CEO
2 companies
Schade Christian S serves as a Director at APRE and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 8 buys and 3 sells. Those positions are worth an estimated $1.5M at current prices.
The biggest single holding is IART (~$1.3M) as Director. The recent filings there lean toward selling, a net 39,145 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 18, 2022 | APRE Aprea Therapeutics, Inc. | Chairman &CEO | Buy | 37,500 | $0.64 | $24,123.75 | +14.7% | +40.8% | -70.1% | |
| Oct 7, 2019 | APRE Aprea Therapeutics, Inc. | President &CEO | Buy | 11,000 | $15.00 | $165,000.00 | New | - | - | |
| May 10, 2019 | IART Integra Lifesciences Holdings Corp | Director | Sale+OE | 15,658 | $51.56 | $807,328.05 | -32.4% | - | - | |
| Mar 5, 2018 | IART Integra Lifesciences Holdings Corp | Director | Sale+OE | 15,658 | $52.88 | $827,987.21 | -34.5% | - | - | |
| May 3, 2016 | IART Integra Lifesciences Holdings Corp | Director | Sale+OE | 7,829 | $70.42 | $551,311.13 | -42.2% | - | - |